norfloxacin has been researched along with carbostyril in 195 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 40 (20.51) | 18.7374 |
| 1990's | 82 (42.05) | 18.2507 |
| 2000's | 45 (23.08) | 29.6817 |
| 2010's | 16 (8.21) | 24.3611 |
| 2020's | 12 (6.15) | 2.80 |
| Authors | Studies |
|---|---|
| Cobbs, CG; Smith, KR | 1 |
| García, I; Pascual, A; Perea, EJ | 1 |
| Iravani, A | 1 |
| Hannan, A | 1 |
| Abo-Askar, H; Qadri, SM; Ueno, Y | 1 |
| Almodovar, E; Burns, JJ; Qadri, SM; Rabea, N; Ueno, Y | 1 |
| Aubert, G; Dorche, G; Pozzetto, B | 1 |
| Arai, S; Gohara, Y; Kawashima, T; Kuwano, K; Matsu-Ura, I | 1 |
| Yoshida, H | 1 |
| Jones, RN | 1 |
| Erwin, ME; Jones, RN | 1 |
| Foleno, B; Fu, KP | 1 |
| Aoyama, H; Fukuda, H; Hirai, K; Hosaka, M; Tomizawa, H; Yasue, T | 1 |
| Mitsuhashi, S; Wakebe, H | 1 |
| Schwark, WS; Vancutsem, PM | 1 |
| Forsgren, A; Hansson, C; Neringer, R; Ode, B | 1 |
| Gootz, TD; Martin, BA | 1 |
| al-Shammary, FJ; el-Houfy, S; Shibl, AM; Tawfik, AF | 1 |
| Cox, CE | 1 |
| Conejo, MC; García, I; Pascual, A; Perea, EJ | 1 |
| Inoue, Y; Ito, K; Kotera, Y; Ohashi, M; Tsukamoto, G | 1 |
| Shen, XJ; Wu, FY; Yang, JG | 1 |
| Esteve, M; Gargallo-Viola, D; Guinea, J; Llovera, S; Roca, X | 1 |
| McDonald, PJ; Pruul, H | 1 |
| Borsa-Lebas, F; Dhib, M; Fillastre, JP; Humbert, G; Leroy, A; Moulin, B | 1 |
| Gemeinhardt, A; Janssen, U; Klotz, U; Unseld, E; Ziegler, G | 1 |
| Hall, MC; Piddock, LJ; Wise, R | 1 |
| Hill, JM; Hobden, JA; Insler, MS; O'Callaghan, RJ; Reidy, JJ | 1 |
| Barnett, G; Carbó, M; de la Torre, R; Segura, J | 1 |
| Prescott, JF; Yielding, KM | 1 |
| Matsumoto, F; Morita, M; Takahashi, T | 1 |
| Bhattacharya, SS; Lal, HM; Lalitha, MK; Nisha, AK; Ramamoorthy, U | 1 |
| Clarke, AM; Zemcov, SJ | 1 |
| Greenwood, D; Kanematsu, M | 1 |
| Courvalin, P; Derlot, E; Poyart-Salmeron, C | 1 |
| Baranowski, J; Kohlbrenner, WE; Shen, LL; Weigl, D | 1 |
| Shen, LL | 1 |
| Baranowski, J; Pernet, AG; Shen, LL | 1 |
| Wyler, DJ | 1 |
| Kotera, Y; Mitsuhashi, S | 1 |
| Amano, M; Arakawa, S; Fujita, Y; Ishigami, J; Kamidono, S; Kanemasa, Y; Kumon, H; Ohmori, H; Suzuki, K; Tanaka, H | 1 |
| Beer, C; Harder, S; Papenburg, A; Shah, PM; Staib, AH; Stille, W | 1 |
| Edlund, C; Lindqvist, L; Nord, CE | 1 |
| Benonisen, E; Dibb, WL; Digranes, A | 1 |
| Felmingham, D; Grüneberg, RN; O'Hare, MD; Ridgway, GL | 2 |
| Cremer, AW; Felmingham, D; Grüneberg, RN; O'Hare, MD; Ridgway, GL; Robbins, MJ; Wall, RA; Williams, AH | 1 |
| Weinstein, MP | 1 |
| Chan, KP; Koh, ST; Sng, EH | 1 |
| Coll, R; Esteve, M; Gargallo, D; Guinea, J; Moros, M; Parés, J; Xicota, MA | 1 |
| Bebear, C; de Barbeyrac, B; Quentin, C; Renaudin, H | 1 |
| Fernandes, PB; Swanson, RN | 1 |
| Nagayama, A; Nakao, T; Taen, H | 1 |
| Oliva, B; Ravagnan, G; Renzini, G; Selan, L | 1 |
| Chin, NX; Neu, HC; Novelli, A | 1 |
| Edwards, R; Greenwood, D; Kanematsu, M | 1 |
| Clark, JK; Manzella, JP | 1 |
| Hirose, T; Inoue, M; Ito, Y; Kato, H; Mitsuhashi, S; Okezaki, E | 1 |
| Coll, R; Esteve, M; Moros, M; Parés, J; Xicota, MA | 2 |
| Oriel, JD | 1 |
| Smith, JT | 2 |
| Neu, HC | 1 |
| Jensen, KM; Madsen, PO | 1 |
| Bebear, C; Cantet, P; Quentin, C; Renaudin, H | 1 |
| Gabriel, FG; Mumtaz, G; Oriel, JD; Ridgway, GL | 1 |
| Peeters, M; Piot, P; Van Dyck, E | 1 |
| Dørflinger, T; Frimodt-Møller, PC; Madsen, PO | 1 |
| Husson, MO; Izard, D; Leclerc, H | 1 |
| Gruninger, RP; Khan, MY; Siddiqui, Y | 1 |
| Cormican, MG; Jones, RN | 1 |
| Aguilar, L; Giménez, MJ; Jiménez de Anta, MT; Marco, F; Marcos, MA; Salvá, P | 1 |
| Fukuyama, M; Imagawa, Y; Kawakami, K; Suda, O | 1 |
| Allemandi, DA; Alovero, FL; Manzo, RH | 1 |
| Davidson, RJ; Drobot, GR; Hoban, DJ; Karlowsky, JA; Philips, R; Zhanel, GG | 1 |
| el-Kersh, TA; Ramadan, MA; Shibl, AM; Tawfik, AF | 1 |
| Fujita, H; Matsuo, I | 1 |
| Aguilar, L; Fernández-Roblas, R; García-Corbeira, P; López, JC; Soriano, F | 1 |
| Davidson, GW; Yu, X; Zipp, GL | 1 |
| Campillo, B; Dupeyron, C; Fouet, P; Leluan, G; Mangeney, N; Sedrati, L | 1 |
| Phillips, I; Power, EG | 1 |
| Foleno, BD; Fu, KP; Lafredo, SC | 1 |
| Conly, JM; DuBois, J; Harding, GK; Martel, AY; Nicolle, LE; Shafran, SD | 1 |
| Riley, CM; Ross, DL; Takusagawa, F; Vander Velde, D | 1 |
| Andrews, JM; Brenwald, N; Wise, R | 1 |
| Benne, RA; Boon, TA; de Hond, HA; de Wit, MA; Havinga, WH; Hoepelman, IM; van Asbeck, FW; Verhoef, J; Visser, MR; Zwinkels, M | 1 |
| Hendrickx, AG; Hummler, H; Richter, WF | 1 |
| Cozzarelli, NR; Khodursky, AB; Zechiedrich, EL | 1 |
| Hale, JA; Knapp, JS; Neal, SW; Rice, RJ; Whittington, WL; Wintersheid, K | 1 |
| Asaoka, T; Imamori, K; Maebashi, K; Matsuda, H; Matsumoto, M; Tahara, Y | 1 |
| Fukuda, S; Inatomi, M; Kanda, Y; Kiuchi, Y; Koide, R; Oguchi, K; Sato, H; Uchida, N | 1 |
| Ooie, T; Sugiyama, Y; Suzuki, H; Terasaki, T | 1 |
| Aguilar, L; Balcabao, IP; Costa, J; Dal-ré, R; Martín, M; Prieto, J; Salvá, P | 1 |
| Hiasa, H; Marians, KJ; Yousef, DO | 1 |
| Chilima, BZ; Okazawa, Y; Tanno, K; Tosaka, M; Yamane, N | 1 |
| Aguilar, L; Caffaratti, J; Dal-Ré, R; Dalet, F; Del Río, G | 1 |
| Chambers, HF; Hackbarth, CJ; Kocagöz, T; Nikaido, H; Rosenberg, EY; Unsal, I | 1 |
| Hanzawa, H; Iwata, Y; Ohya, S; Sugawara, M; Tabata, F; Takenouchi, T | 1 |
| Ballesta, S; García, I; Pascual, A; Perea, EJ | 1 |
| Akahane, K; Fukuda, H; Ito, Y; Kimura, Y; Miyasaka, T | 1 |
| Bouquet, S; Couet, W; Courtois, P; Delon, A; Huguet, F; Vierfond, JM | 1 |
| Capron, MH; Guibert, J; Herman, H | 1 |
| Fabian, I; Gruss, T; Kletter, Y; Shalit, I; Weiss, K | 1 |
| Aguilar, L; Costa, J; Dal-Ré, R; Giménez, MJ; Prieto, J | 1 |
| Dvorak, T; Ho, DH; LeBlanc, B; Rolston, KV; Streeter, H | 1 |
| Brumbaugh, GW; Lizarraga, RE; Ocampo, CL; Sumano, LH | 1 |
| Barbosa, J; Bergés, R; Sanz-Nebot, V | 1 |
| Chignell, CF; Martínez, L | 1 |
| Albini, A; Fasani, E; Profumo, A | 1 |
| Bellaiche, M; Ershov, E; Hanji, V; Shlosberg, A; Soback, S; Weisman, Y | 1 |
| Bhaduri, AP; Chauhan, PM; Pandey, VC; Puri, SK; Shukla, A; Srivastava, S; Srivastava, SK | 1 |
| Barbosa, J; Barrón, D; Jiménez-Lozano, E | 1 |
| Hurley, LH; Kwok, Y; Zeng, Q | 1 |
| Fukuda, M; Sasaki, K; Yoshitake, Y | 1 |
| Frimpong, EK; Honda, T; Voravuthikunchai, SP; Yoh, M | 1 |
| Jiménez de Anta, MT; Martín-Sánchez, AM; Ruiz, J; Tavío, MM; Vila, J | 1 |
| Gomi, H; Hatanaka, K; Kawada, A; Matsuo, I | 1 |
| Akagi, M; Fukuishi, N; Kanoh, R; Matsui, N | 1 |
| Chen, YL; Fang, KC; Sheu, JY; Tzeng, CC; Wang, TC | 1 |
| Castell, JV; Morlière, P; Ouédraogo, G; Santus, R | 1 |
| Burke, TJ; Campbell, KL; Kakoma, I; Kim, CH; Koo, HY; McKiernan, BC; Oluoch, AO; Siegel, AM; Weisiger, RM | 1 |
| Andrews, JM; Boswell, FJ; Wise, R | 1 |
| Bai, ZZ; Guan, DW; Zhang, QS | 1 |
| Guo, HY; Li, XH; Miao, H; Tian, ZM; Yu, LX | 1 |
| Iwatsu, M; Kanai, A; Sado, K; Tian, X | 1 |
| Bellaiche, M; Ershov, E; Gips, M; Hanji, V; Shlosberg, A; Soback, S | 1 |
| Brewer, PD; Buxton, TB; Farcasiu, D; Hartmann, JF; Herczegh, P; Kovács-Kulyassa, A; McPherson, JC; Plowman, KM; Stroebel, GG; Sztaricskai, F | 1 |
| Bauer, TM; Bory, F; Clemente, G; Follo, A; Navasa, M; Planas, R; Rodés, J; Vaquer, P; Vargas, V; Vila, J | 1 |
| Schaeffer, AJ | 1 |
| Fukuda, H; Kawamura, Y | 1 |
| Fukumoto, H; Furubo, S; Hayakawa, H; Kawamura, Y; Kizawa, K; Miyazaki, M; Morita, T; Nagai, A; Sanzen, T | 1 |
| Monti, S; Sortino, S | 1 |
| Li, JL; Ma, XC; Tu, ZH; Xin, J; Zhang, T | 1 |
| Wos, M; Zünkler, BJ | 1 |
| Kim, IS; Kim, MR; Lee, CJ; Lee, MH; Shim, JH | 1 |
| Dong, C; Du, L; Jin, W; Liu, C | 1 |
| Ono, C; Tanaka, M | 1 |
| Dong, C; Feng, XH; Li, JQ | 1 |
| Hiasa, H; Shea, ME | 1 |
| Kawai, M; Mashima, Y; Mochizuki, H; Yamada, K; Yamada, M | 1 |
| Foroumadi, A; Kiani, Z; Mansouri, S; Rahmani, A | 1 |
| Chiang, CH; Lu, DW; Tai, MC | 1 |
| Hiasa, H; Pfeiffer, ES | 1 |
| Amin, AS; Ragab, GH | 1 |
| Duan, GC; Xi, YL; Zhu, JY | 1 |
| Andersson, DI; Kugelberg, E; Löfmark, S; Wretlind, B | 1 |
| Biswas, A; Kumar, AA; Ramakrishnan, MA; Shivachandra, SB; Singh, VP; Srivastava, SK | 1 |
| Francés, R; Gascón, I; Más, P; Pascual, S; Pérez-Mateo, M; Plazas, J; Sánchez, J; Such, J; Zapater, P | 1 |
| Holzgrabe, U; Kiefer, W; Neugebauer, U; Popp, J; Schmitt, M; Szeghalmi, A | 1 |
| Abba, M; Donnelly, J; Hussain, B; Shervington, LA | 1 |
| Minta, M; Wilk, I; Zmudzki, J | 1 |
| Bassily, S; El Masry, NA; Haberberger, RL; Mikhail, I; Woody, JN; Yassa, M; Zakaria, S | 1 |
| Depta, JP; Pichler, WJ; Schmid, DA | 1 |
| Romero, IC; Saravia, NG; Walker, J | 1 |
| Depta, JP; Lüthi, M; Pichler, WJ; Schmid, DA | 1 |
| Ishikawa, K; Kawai, M; Mochizuki, H; Yamada, M | 1 |
| Ni, YN; Zhang, GW | 1 |
| Andreeva, I; Rafalsky, V; Rjabkova, E | 1 |
| Li, XD; Liu, YC; Xu, WH; Zhang, G; Zou, SC | 1 |
| Ambade, V; Somani, BL | 1 |
| Chen, X; Hua, H; Ji, C; Lin, X; Liu, Y; Tang, S; Yue, Z | 1 |
| Jin, L; Shen, B; Wang, X; Zhao, H | 1 |
| Alba, V; Alcalde, E; Blasco, MD; Esteve, C; Marti, S; Sánchez-Céspedes, J; Vila, J | 1 |
| Chen, XF; Li, WY; Xuan, CS | 1 |
| Jia, YX; Liu, YM; Tian, W | 1 |
| Lin, B | 1 |
| Li, YW; Mo, CH; Su, QY; Tai, YP; Wang, JY; Wu, XL; Zhang, Y | 1 |
| Aedo, S; Liu, IF; Tse-Dinh, YC | 1 |
| Jiang, W; Korshin, GV; Liu, C; Nanaboina, V | 1 |
| Carson, L; Irwin, NJ; McCoy, CP | 1 |
| Emami, S; Faramarzi, MA; Foroumadi, A; Ghafouri, E; Irannejad, H; Samadi, N | 1 |
| Cai, QH; Chen, GH; Chen, P; Guo, X; Meng, HL; Tian, YF | 1 |
| Chen, X; Han, F; Hu, Y; Lü, Y; Qiu, J; Song, W; Zheng, P; Zhou, F; Zhou, X | 1 |
| Companyó, R; Guiteras, J; Jiménez, V | 1 |
| Ding, X; Liang, W; Sun, Y; Xiong, W; Zeng, Z; Zhang, Y; Zhong, X | 1 |
| He, W; Huo, X; Li, S; Li, Z; Ma, C; Song, X; Tian, J; Wei, W | 1 |
| Botello, E; García-Cañas, A; González-Soltero, R; Mendoza-Chamizo, B; Mohedano, RB | 1 |
| Geng, RX; Kumar, KV; Zhang, L; Zhou, CH | 1 |
| Kang, H; Lin, L; Luo, Y; Tu, X; Wu, W; Xie, L; Yue, Z; Zhang, Y | 1 |
| Díaz-De-Alba, P; Docobo-Perez, F; Machuca, J; Ortiz, M; Pascual, Á; Recacha, E; Rodríguez-Martínez, JM | 1 |
| Barba, MJ; Bou, G; Gómara, M; Oviaño, M; Pascual, Á; Sparbier, K | 1 |
| Li, G; Li, Y; Wang, X; Xie, Y; Yu, M | 1 |
| Hu, S; Huang, Z; Lai, WH; Peng, J; Wang, C | 1 |
| Bandyopadhyay, B; Giri, N; Roy, B; Tousif Ahamed, SK | 1 |
| Chen, Y; Gin, KY; Hassan, M; He, Y; Huang, Y; Yang, J; Zhang, B; Zhang, X | 1 |
| Cabañas, R; Domínguez-Ortega, J; Fiandor, A; González-Muñoz, M; Lluch-Bernal, M; Loli-Ausejo, D; Vílchez-Sánchez, F | 1 |
| Chang, C; Chen, T; Li, J; Liu, F; Lu, X; Niwa, O; Wang, Q; Xue, Q; Zhou, T | 1 |
| Bai, Y; Du, P; Han, S; Huang, H; Li, X; Wang, T; Wang, Z; Zhou, Z | 1 |
| Boyd, A; O'Boyle, N | 1 |
| Chu, K; Gu, L; Hua, Z; Li, X; Liu, Y; Lu, Y; Luan, C; Wu, J | 1 |
| Do, KH; Lee, WK; Seo, K | 1 |
| Battini, N; Ou, JM; Zhang, J; Zhang, L; Zhang, SL; Zhou, CH | 1 |
| Geng, C; Li, X; Song, S; Tang, Z; Wang, C; Yang, Y | 1 |
| Chen, JP; Li, S; Li, SR; Peng, XM; Zeng, CM; Zhou, CH | 1 |
5 review(s) available for norfloxacin and carbostyril
| Article | Year |
|---|---|
Pharmacokinetics of quinolones in renal insufficiency.
Topics: Anti-Infective Agents; Ciprofloxacin; Enoxacin; Fleroxacin; Fluoroquinolones; Glomerular Filtration Rate; Half-Life; Humans; Kidney Failure, Chronic; Metabolic Clearance Rate; Norfloxacin; Ofloxacin; Pefloxacin; Quinolones | 1990 |
Ciprofloxacin in the treatment of gonorrhoea and non-gonococcal urethritis.
Topics: 4-Quinolones; Anti-Infective Agents; Anti-Infective Agents, Urinary; Chlamydia Infections; Chlamydia trachomatis; Ciprofloxacin; Gonorrhea; Humans; Norfloxacin; Quinolines; Quinolones; Urethritis | 1986 |
The expanding role of fluoroquinolones.
Topics: Anti-Infective Agents; Anti-Infective Agents, Urinary; Ciprofloxacin; Enoxacin; Fluoroquinolones; Gatifloxacin; Humans; Levofloxacin; Norfloxacin; Ofloxacin; Quinolones; Urinary Tract Infections | 2002 |
Quinolones for uncomplicated acute cystitis in women.
Topics: Acute Disease; Adult; Anti-Infective Agents, Urinary; Ciprofloxacin; Cystitis; Female; Fluoroquinolones; Humans; Levofloxacin; Norfloxacin; Ofloxacin; Pefloxacin; Quinolones; Randomized Controlled Trials as Topic | 2006 |
Norfloxacin versus alternative antibiotics for prophylaxis of spontaneous bacteria peritonitis in cirrhosis: a systematic review and meta-analysis.
Topics: Anti-Bacterial Agents; Humans; Liver Cirrhosis; Norfloxacin; Quinolones; Rifaximin | 2023 |
14 trial(s) available for norfloxacin and carbostyril
| Article | Year |
|---|---|
Efficacy of lomefloxacin as compared to norfloxacin in the treatment of uncomplicated urinary tract infections in adults.
Topics: Acute Disease; Adolescent; Adult; Aged; Aged, 80 and over; Anti-Infective Agents; Drug Administration Schedule; Female; Fluoroquinolones; Humans; Male; Middle Aged; Norfloxacin; Quinolones; Single-Blind Method; Treatment Outcome; Urinary Tract Infections | 1992 |
Lomefloxacin versus norfloxacin in the treatment of uncomplicated urinary tract infections: three-day versus seven-day treatment. The South Swedish Lolex Study Group.
Topics: Adolescent; Adult; Aged; Anti-Infective Agents; Double-Blind Method; Drug Administration Schedule; Female; Fluoroquinolones; Humans; Middle Aged; Norfloxacin; Quinolones; Sweden; Urinary Tract Infections | 1992 |
Oral temafloxacin compared to norfloxacin for the treatment of complicated urinary tract infections.
Topics: Administration, Oral; Adolescent; Adult; Aged; Aged, 80 and over; Anti-Infective Agents; Double-Blind Method; Female; Fluoroquinolones; Humans; Male; Middle Aged; Norfloxacin; Quinolones; Urinary Tract Infections | 1991 |
[A comparative study on lomefloxacin and norfloxacin in the treatment of acute uncomplicated cystitis].
Topics: Acute Disease; Adolescent; Adult; Aged; Anti-Infective Agents; Bacteria; Child; Clinical Trials as Topic; Cystitis; Double-Blind Method; Drug Administration Schedule; Drug Resistance, Microbial; Female; Fluoroquinolones; Humans; Middle Aged; Norfloxacin; Quinolones; Recurrence | 1989 |
4-quinolones inhibit biotransformation of caffeine.
Topics: Adult; Biotransformation; Caffeine; Ciprofloxacin; Dose-Response Relationship, Drug; Drug Interactions; Enoxacin; Humans; Male; Molecular Structure; Norfloxacin; Ofloxacin; Pipemidic Acid; Quinolones; Random Allocation; Theophylline | 1988 |
Comparison of rufloxacin and norfloxacin effects on faecal flora.
Topics: Adult; Anti-Infective Agents; Bacteroides fragilis; Colony Count, Microbial; Escherichia coli; Feces; Fluoroquinolones; Humans; Male; Norfloxacin; Quinolones | 1995 |
Treatment of acute uncomplicated urinary tract infections with 3 days of lomefloxacin compared with treatment with 3 days of norfloxacin.
Topics: Acute Disease; Adolescent; Adult; Aged; Anti-Infective Agents; Canada; Double-Blind Method; Female; Fluoroquinolones; Humans; Middle Aged; Norfloxacin; Prospective Studies; Quinolones; Treatment Outcome; Urinary Tract Infections | 1993 |
Safety and efficacy of lomefloxacin versus norfloxacin in the treatment of complicated urinary tract infections.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Infective Agents; Female; Fluoroquinolones; Humans; Male; Middle Aged; Norfloxacin; Quinolones; Treatment Outcome; Urinary Tract Infections; Urine | 1993 |
Ex vivo antibacterial properties of rufloxacin compared with those of norfloxacin in a study with healthy volunteers.
Topics: Adult; Anti-Infective Agents; Bacteriuria; Cross-Over Studies; Escherichia coli Infections; Fluoroquinolones; Humans; Male; Microbial Sensitivity Tests; Norfloxacin; Quinolones; Serum Bactericidal Test; Staphylococcal Infections | 1996 |
Single-dose rufloxacin versus 3-day norfloxacin treatment of uncomplicated cystitis: clinical evaluation and pharmacodynamic considerations.
Topics: Adult; Anti-Infective Agents; Cystitis; Escherichia coli Infections; Female; Fluoroquinolones; Humans; Microbial Sensitivity Tests; Middle Aged; Norfloxacin; Quinolones; Recurrence | 1996 |
[Treatment of uncomplicated recurrent cystitis in women: lomefloxacin versus norfloxacin].
Topics: Adult; Anti-Infective Agents; Cystitis; Drug Administration Schedule; Female; Fluoroquinolones; Humans; Middle Aged; Norfloxacin; Patient Acceptance of Health Care; Quinolones; Recurrence; Urinary Tract Infections | 1997 |
Suspicion of quinolone active metabolite following discrepancy between predicted and experimental urine bactericidal activities.
Topics: Anti-Infective Agents; Area Under Curve; Escherichia coli; Fluoroquinolones; Humans; Norfloxacin; Predictive Value of Tests; Quinolones; Staphylococcus aureus | 1997 |
Effectiveness of two fluoroquinolones for the treatment of chronic respiratory disease outbreak in broilers.
Topics: Animals; Anti-Infective Agents; Body Weight; Chickens; Chronic Disease; Disease Outbreaks; Enrofloxacin; Escherichia coli Infections; Fluoroquinolones; Mycoplasma Infections; Nicotinic Acids; Norfloxacin; Poultry Diseases; Probability; Quinolones; Respiratory Tract Infections; Survival Analysis | 1998 |
Daily norfloxacin is more effective than weekly rufloxacin in prevention of spontaneous bacterial peritonitis recurrence.
Topics: Aged; Anti-Infective Agents; Female; Fluoroquinolones; Humans; Liver Cirrhosis; Male; Middle Aged; Norfloxacin; Peritonitis; Prospective Studies; Quinolones; Secondary Prevention; Treatment Outcome | 2002 |
176 other study(ies) available for norfloxacin and carbostyril
| Article | Year |
|---|---|
In vitro activity of sparfloxacin and three other fluoroquinolones against methicillin-resistant Staphylococcus aureus and Staphylococcus epidermidis.
Topics: Anti-Infective Agents; Ciprofloxacin; Fluoroquinolones; Methicillin; Methicillin Resistance; Microbial Sensitivity Tests; Norfloxacin; Ofloxacin; Quinolones; Staphylococcus aureus; Staphylococcus epidermidis | 1992 |
Comparative penetration of lomefloxacin and other quinolones into human phagocytes.
Topics: Analysis of Variance; Anti-Infective Agents; Ascitic Fluid; Ciprofloxacin; Fluoroquinolones; Humans; In Vitro Techniques; Macrophages; Neutrophils; Norfloxacin; Ofloxacin; Quinolones | 1992 |
Comparative in vitro activity of enoxacin and other fluoroquinolones against multi-resistant strains of Salmonella typhi.
Topics: Ampicillin; Anti-Infective Agents; Chloramphenicol; Drug Resistance, Microbial; Enoxacin; Fluoroquinolones; Humans; Microbial Sensitivity Tests; Norfloxacin; Pefloxacin; Quinolones; Salmonella typhi; Species Specificity; Trimethoprim, Sulfamethoxazole Drug Combination; Typhoid Fever | 1992 |
Antibacterial activity of the new quinolone CI-960 (PD 127391) against clinical isolates at a major tertiary care center in Saudi Arabia.
Topics: Anti-Infective Agents; Ciprofloxacin; Enterobacter cloacae; Enterobacteriaceae; Fluoroquinolones; Gram-Negative Bacteria; Hospitals, Urban; Klebsiella pneumoniae; Microbial Sensitivity Tests; Norfloxacin; Pseudomonas aeruginosa; Quinolones; Saudi Arabia | 1992 |
In vitro activity of sparfloxacin (CI-978), a new broad-spectrum fluoroquinolone.
Topics: Anti-Infective Agents; Ciprofloxacin; Enterobacteriaceae; Fluoroquinolones; Gram-Negative Bacteria; Gram-Positive Cocci; Microbial Sensitivity Tests; Norfloxacin; Quinolones | 1992 |
Emergence of quinolone-imipenem cross-resistance in Pseudomonas aeruginosa after fluoroquinolone therapy.
Topics: Anti-Infective Agents; Drug Resistance, Microbial; Drug Therapy, Combination; Fluoroquinolones; Humans; Imipenem; Microbial Sensitivity Tests; Mutation; Naphthyridines; Norfloxacin; Pseudomonas aeruginosa; Pseudomonas Infections; Quinolones | 1992 |
[In vitro antimicrobial activities of new quinolone antibiotics against Mycoplasma pneumoniae].
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Ciprofloxacin; Drug Resistance, Microbial; Enoxacin; Fluoroquinolones; Macrolides; Mycoplasma pneumoniae; Norfloxacin; Ofloxacin; Quinolones; Tetracyclines | 1992 |
[Characterization of the Staphylococcus aureus norA gene, which confers resistance to hydrophilic quinolones].
Topics: Amino Acid Sequence; Base Sequence; Drug Resistance, Microbial; Genes, Bacterial; Methicillin Resistance; Molecular Sequence Data; Norfloxacin; Quinolones; Staphylococcus aureus | 1992 |
In vitro evaluation of E-4695, a new fluoro-naphthyridine.
Topics: Anti-Bacterial Agents; Azetidines; Bacteria; Ciprofloxacin; Drug Evaluation, Preclinical; Enoxacin; Fleroxacin; Fluoroquinolones; Microbial Sensitivity Tests; Naphthyridines; Norfloxacin; Ofloxacin; Quinolones | 1992 |
In vitro activity of CP-74667 compared with four other fluoroquinolones.
Topics: Anti-Infective Agents; Ciprofloxacin; Drug Evaluation, Preclinical; Enoxacin; Enterobacteriaceae; Fluoroquinolones; Gram-Negative Bacteria; Gram-Positive Cocci; Humans; Microbial Sensitivity Tests; Norfloxacin; Ofloxacin; Quinolones | 1992 |
In vitro activity of l-ofloxacin against norfloxacin-resistant coagulase-negative staphylococci.
Topics: Anti-Bacterial Agents; Coagulase; Drug Resistance, Microbial; Microbial Sensitivity Tests; Norfloxacin; Ofloxacin; Quinolones; Staphylococcus | 1992 |
In vitro and in vivo antibacterial activities of AM-1155, a new 6-fluoro-8-methoxy quinolone.
Topics: Animals; Anti-Infective Agents; Bacterial Infections; Ciprofloxacin; DNA Topoisomerases, Type II; Drug Evaluation, Preclinical; Fluoroquinolones; Gatifloxacin; Male; Mice; Mice, Inbred ICR; Microbial Sensitivity Tests; Norfloxacin; Ofloxacin; Piperazines; Quinolones; Tissue Distribution | 1992 |
Comparative in vitro activities of a new quinolone, OPC-17116, possessing potent activity against gram-positive bacteria.
Topics: Anti-Infective Agents; Ciprofloxacin; DNA Topoisomerases, Type II; Fluoroquinolones; Gram-Positive Bacteria; Microbial Sensitivity Tests; Norfloxacin; Ofloxacin; Piperazines; Quinolones; Staphylococcus aureus | 1992 |
Effects of fluoroquinolone antimicrobials alone and in conjunction with theophylline on seizures in amygdaloid kindled rats. Mechanistic and pharmacokinetic study.
Topics: 2-Chloroadenosine; Amygdala; Animals; Anti-Infective Agents; Chromatography, High Pressure Liquid; Diazepam; Dose-Response Relationship, Drug; Electrodes, Implanted; Enrofloxacin; Female; Fluoroquinolones; Kindling, Neurologic; Norfloxacin; Quinolones; Rats; Rats, Sprague-Dawley; Seizures; Theophylline | 1992 |
Characterization of high-level quinolone resistance in Campylobacter jejuni.
Topics: Anti-Infective Agents; Campylobacter jejuni; Ciprofloxacin; DNA Topoisomerases, Type II; DNA, Superhelical; Drug Resistance, Microbial; Fluoroquinolones; Microbial Sensitivity Tests; Mutation; Nalidixic Acid; Norfloxacin; Quinolones; Topoisomerase II Inhibitors | 1991 |
Determination of lomefloxacin in biological fluids by high-performance liquid chromatography and a microbiological method.
Topics: Animals; Anti-Infective Agents; Chromatography, High Pressure Liquid; Fluoroquinolones; Humans; Mice; Microbiological Techniques; Norfloxacin; Quinolones | 1991 |
Fluorometric and high-performance liquid chromatographic measurement of quinolone uptake by human neutrophils.
Topics: Anti-Infective Agents; Chromatography, High Pressure Liquid; Ciprofloxacin; Fleroxacin; Fluorescence; Fluoroquinolones; Humans; Neutrophils; Norfloxacin; Ofloxacin; Quinolones | 1991 |
Antibacterial activity of a new tetracyclic quinolone, No. 5290, against norfloxacin- and ciprofloxacin-resistant strains of Staphylococcus aureus.
Topics: Anti-Infective Agents; Chromatography, High Pressure Liquid; Ciprofloxacin; Drug Resistance, Microbial; Fluoroquinolones; Mutation; Norfloxacin; Piperazines; Quinolones; Staphylococcus aureus; Thiazoles | 1991 |
[Quinolones in the treatment of acute amebic dysentery].
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Child; Child, Preschool; Dysentery, Amebic; Female; Humans; Infant; Male; Metronidazole; Middle Aged; Norfloxacin; Pipemidic Acid; Quinolones | 1991 |
In vitro and in vivo antibacterial activities of E-4497, a new 3-amine-3-methyl-azetidinyl tricyclic fluoroquinolone.
Topics: Animals; Anti-Infective Agents; Bacteria; Bacterial Infections; Ciprofloxacin; Drug Evaluation, Preclinical; Drug Interactions; Fluoroquinolones; Magnesium; Male; Mice; Microbial Sensitivity Tests; Norfloxacin; Ofloxacin; Quinolones | 1991 |
Lomefloxacin-induced modification of the kinetics of growth of gram-negative bacteria and susceptibility to phagocytic killing by human neutrophils.
Topics: Anti-Infective Agents; Cell Division; Ciprofloxacin; Escherichia coli; Fluoroquinolones; Gram-Negative Bacteria; Humans; Neutrophils; Norfloxacin; Nucleic Acids; Phagocytosis; Pseudomonas aeruginosa; Quinolones; Tritium | 1990 |
Possible interaction of fluoroquinolones with the benzodiazepine-GABAA-receptor complex.
Topics: Adult; Animals; Brain Chemistry; Ciprofloxacin; Double-Blind Method; Electroencephalography; Female; Flunitrazepam; Humans; In Vitro Techniques; Male; Middle Aged; Norfloxacin; Ofloxacin; Quinolones; Radioligand Assay; Random Allocation; Rats; Rats, Inbred Strains; Receptors, GABA-A; Synaptic Membranes | 1990 |
Mechanism of action of lomefloxacin.
Topics: Anti-Infective Agents; Bacteria; Ciprofloxacin; DNA Topoisomerases, Type II; DNA, Bacterial; DNA, Superhelical; Fluoroquinolones; Kinetics; Microbial Sensitivity Tests; Norfloxacin; Quinolones; Rec A Recombinases | 1990 |
Quinolones in collagen shields to treat aminoglycoside-resistant pseudomonal keratitis.
Topics: Animals; Ciprofloxacin; Collagen; Colony Count, Microbial; Cornea; Drug Resistance, Microbial; Eye Infections, Bacterial; Keratitis; Norfloxacin; Pharmaceutical Vehicles; Pseudomonas aeruginosa; Quinolones; Rabbits; Tobramycin | 1990 |
Pharmacokinetic determination of relative potency of quinolone inhibition of caffeine disposition.
Topics: Caffeine; Ciprofloxacin; Drug Interactions; Enoxacin; Humans; Male; Models, Biological; Norfloxacin; Ofloxacin; Pipemidic Acid; Quinolones | 1990 |
In vitro susceptibility of selected veterinary bacterial pathogens to ciprofloxacin, enrofloxacin and norfloxacin.
Topics: Actinobacillus; Actinomyces; Anti-Infective Agents; Ciprofloxacin; Corynebacterium; Enrofloxacin; Erysipelothrix; Fluoroquinolones; Haemophilus; In Vitro Techniques; Microbial Sensitivity Tests; Norfloxacin; Pasteurella; Quinolones; Rhodococcus; Streptococcus | 1990 |
[Therapeutic drug monitoring of fluoroquinolone].
Topics: Anti-Infective Agents; Bile; Biological Assay; Biological Availability; Chromatography, High Pressure Liquid; Ciprofloxacin; Enoxacin; Fluoroquinolones; Humans; Naphthyridines; Norfloxacin; Ofloxacin; Quinolones; Sputum | 1990 |
Susceptibility pattern of bacterial isolates to lomefloxacin.
Topics: Anti-Infective Agents; Bacteria; Ciprofloxacin; Enoxacin; Fluoroquinolones; Humans; Nalidixic Acid; Norfloxacin; Quinolones | 1990 |
Comparative in vitro activity of lomefloxacin, a new difluoroquinolone.
Topics: Anti-Infective Agents; Bacteria, Aerobic; Bacteria, Anaerobic; Ceftazidime; Ciprofloxacin; Drug Evaluation, Preclinical; Fluoroquinolones; Gentamicins; Microbial Sensitivity Tests; Norfloxacin; Quinolones | 1989 |
Studies on the emergence of resistance to lomefloxacin in vitro.
Topics: Anti-Infective Agents; Ciprofloxacin; Cystitis; Drug Resistance, Microbial; Escherichia coli; Fluoroquinolones; Klebsiella pneumoniae; Microbial Sensitivity Tests; Models, Biological; Norfloxacin; Quinolones | 1989 |
Antibacterial and plasmid curing activity of lomefloxacin in vitro.
Topics: Anti-Infective Agents; Enterobacteriaceae; Escherichia coli; Fluoroquinolones; Microbial Sensitivity Tests; Norfloxacin; Pefloxacin; Plasmids; Pseudomonas aeruginosa; Quinolones; Staphylococcus aureus | 1989 |
Mechanism of quinolone inhibition of DNA gyrase. Appearance of unique norfloxacin binding sites in enzyme-DNA complexes.
Topics: Binding Sites; DNA, Bacterial; Escherichia coli; Kinetics; Macromolecular Substances; Norfloxacin; Plasmids; Quinolones; Topoisomerase II Inhibitors | 1989 |
A reply: "Do quinolones bind to DNA?"--Yes.
Topics: Animals; Cattle; DNA, Superhelical; Escherichia coli; Fluorescence; Norfloxacin; Quinolones | 1989 |
Mechanism of inhibition of DNA gyrase by quinolone antibacterials: specificity and cooperativity of drug binding to DNA.
Topics: Anti-Bacterial Agents; Binding, Competitive; DNA, Bacterial; Kinetics; Norfloxacin; Polydeoxyribonucleotides; Quinolones; Topoisomerase II Inhibitors | 1989 |
Fluoroquinolones for malaria: the newest kid on the block?
Topics: Antimalarials; Drug Resistance; Drug Therapy, Combination; History, 20th Century; History, Ancient; Humans; Malaria; Molecular Structure; Norfloxacin; Quinolones | 1989 |
In vitro and in vivo antibacterial activities of KB-5246, a new tetracyclic quinolone.
Topics: Animals; Anti-Infective Agents; Bacterial Infections; Ciprofloxacin; Fluoroquinolones; Male; Mice; Microbial Sensitivity Tests; Norfloxacin; Ofloxacin; Phenalenes; Quinolones | 1989 |
Norfloxacin binds to human fecal material.
Topics: Adult; Bacteroides fragilis; Enterococcus faecalis; Feces; Female; Humans; Male; Middle Aged; Norfloxacin; Quinolones | 1988 |
In vitro activities of ciprofloxacin, ofloxacin, norfloxacin and rosoxacin compared with cinoxacin and trimethoprim.
Topics: 4-Quinolones; Acinetobacter; Anti-Infective Agents; Anti-Infective Agents, Urinary; Cinoxacin; Ciprofloxacin; Enterobacteriaceae; Humans; Microbial Sensitivity Tests; Norfloxacin; Ofloxacin; Oxazines; Pseudomonas aeruginosa; Quinolines; Quinolones; Trimethoprim | 1985 |
The comparative in vitro activity of twelve 4-quinolone antimicrobials against enteric pathogens.
Topics: 4-Quinolones; Aeromonas; Anti-Bacterial Agents; Anti-Infective Agents; Campylobacter fetus; Cinoxacin; Ciprofloxacin; Diarrhea; Enoxacin; Fluoroquinolones; Humans; In Vitro Techniques; Intestines; Microbial Sensitivity Tests; Nalidixic Acid; Naphthyridines; Norfloxacin; Ofloxacin; Oxazines; Oxolinic Acid; Pefloxacin; Pipemidic Acid; Quinolines; Quinolizines; Quinolones; Salmonella; Shigella; Vibrio cholerae; Vibrio parahaemolyticus; Yersinia enterocolitica | 1985 |
The comparative activity of twelve 4-quinolone antimicrobials against Haemophilus influenzae and Streptococcus pneumoniae.
Topics: 4-Quinolones; Anti-Infective Agents; Cinoxacin; Ciprofloxacin; Enoxacin; Fluoroquinolones; Haemophilus influenzae; Humans; Microbial Sensitivity Tests; Nalidixic Acid; Naphthyridines; Norfloxacin; Ofloxacin; Oxazines; Oxolinic Acid; Pefloxacin; Pipemidic Acid; Quinolines; Quinolizines; Quinolones; Streptococcus pneumoniae | 1985 |
Comparative in vitro studies with 4-quinolone antimicrobials.
Topics: 4-Quinolones; Anti-Infective Agents; Bacteria; Cinoxacin; Ciprofloxacin; Enoxacin; Fluoroquinolones; Humans; Microbial Sensitivity Tests; Nalidixic Acid; Naphthyridines; Norfloxacin; Ofloxacin; Oxazines; Oxolinic Acid; Pefloxacin; Pipemidic Acid; Quinolines; Quinolizines; Quinolones | 1985 |
Comparative in vitro activity of lomefloxacin and other antimicrobials against 597 microorganisms causing bacteremia.
Topics: Anti-Bacterial Agents; Bacteria; Cefotaxime; Ceftazidime; Enoxacin; Fluoroquinolones; Humans; Imipenem; Microbial Sensitivity Tests; Norfloxacin; Quinolones; Sepsis; Tobramycin | 1988 |
Susceptibility of Neisseria gonorrhoeae to pefloxacin.
Topics: 4-Quinolones; Anti-Bacterial Agents; Humans; Neisseria gonorrhoeae; Norfloxacin; Pefloxacin; Penicillinase; Quinolines; Quinolones | 1987 |
Activity of E-3846, a new fluoroquinolone, in vitro and in experimental cystitis and pyelonephritis in rats.
Topics: Animals; Anti-Infective Agents; Anti-Infective Agents, Urinary; Bacteria; Chemical Phenomena; Chemistry; Ciprofloxacin; Cystitis; Disease Models, Animal; Enterobacteriaceae; Escherichia coli Infections; Female; Fluoroquinolones; Hydrogen-Ion Concentration; Klebsiella Infections; Norfloxacin; Proteus Infections; Pseudomonas aeruginosa; Pseudomonas Infections; Pyelonephritis; Quinolines; Quinolones; Rats; Rats, Inbred Strains; Staphylococcus; Streptococcal Infections; Streptococcus | 1988 |
[In vitro activity of new quinolones against Mycoplasma pathogenic to humans].
Topics: 4-Quinolones; Anti-Bacterial Agents; Ciprofloxacin; Enoxacin; Humans; Microbial Sensitivity Tests; Mycoplasma; Mycoplasma pneumoniae; Mycoplasmataceae; Naphthyridines; Norfloxacin; Ofloxacin; Oxazines; Pefloxacin; Quinolines; Quinolones; Ureaplasma | 1988 |
Correlation of in vitro activities of the fluoroquinolones to their in vivo efficacies.
Topics: Animals; Anti-Infective Agents; Ciprofloxacin; Enoxacin; Fleroxacin; Fluoroquinolones; Mice; Microbial Sensitivity Tests; Naphthyridines; Norfloxacin; Ofloxacin; Pefloxacin; Quinolones | 1988 |
In vitro activities of ofloxacin and four other new quinoline-carboxylic acids against Chlamydia trachomatis.
Topics: Anti-Infective Agents; Chlamydia trachomatis; Ciprofloxacin; Doxycycline; Fleroxacin; Fluoroquinolones; Minocycline; Norfloxacin; Ofloxacin; Quinolones | 1988 |
Inhibition of conjugal transfer by new quinolinic compounds.
Topics: 4-Quinolones; Anti-Bacterial Agents; Anti-Infective Agents; Ciprofloxacin; Conjugation, Genetic; Escherichia coli; Nalidixic Acid; Norfloxacin; Quinolines; Quinolones | 1985 |
In vitro activity of lomefloxacin (SC-47111; NY-198), a difluoroquinolone 3-carboxylic acid, compared with those of other quinolones.
Topics: Anaerobiosis; Anti-Bacterial Agents; Bacteria; Ciprofloxacin; Drug Resistance, Microbial; Enoxacin; Fluoroquinolones; Humans; Hydrogen-Ion Concentration; Magnesium; Naphthyridines; Norfloxacin; Ofloxacin; Oxazines; Quinolines; Quinolones | 1988 |
Laboratory assessment of lomefloxacin (SC-47111) in comparison with norfloxacin.
Topics: Anti-Bacterial Agents; Bacteria; Bacterial Infections; Fluoroquinolones; Humans; Microbial Sensitivity Tests; Norfloxacin; Quinolones; Staphylococcus | 1988 |
Effects of quinolones on mitogen-stimulated human mononuclear leucocytes.
Topics: 4-Quinolones; Adult; Anti-Infective Agents; Ciprofloxacin; Fluoroquinolones; Humans; In Vitro Techniques; Lymphocyte Activation; Norfloxacin; Phytohemagglutinins; Quinolines; Quinolones | 1988 |
In vitro and in vivo activity of NY-198, a new difluorinated quinolone.
Topics: Animals; Anti-Infective Agents; Bacterial Infections; Fluoroquinolones; Male; Mice; Microbial Sensitivity Tests; Norfloxacin; Ofloxacin; Oxazines; Pipemidic Acid; Quinolines; Quinolones | 1987 |
In vitro activity of E-3846, a new fluoroquinolone, against gram-negative and gram-positive bacteria.
Topics: Anti-Infective Agents; Ciprofloxacin; Fluoroquinolones; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Microbial Sensitivity Tests; Molecular Structure; Norfloxacin; Quinolones | 1987 |
Frequency and expression of mutational resistance to the 4-quinolone antibacterials.
Topics: 4-Quinolones; Anti-Bacterial Agents; Cinoxacin; Ciprofloxacin; Drug Resistance, Microbial; Enoxacin; Escherichia coli; Fluoroquinolones; Mutation; Nalidixic Acid; Naphthyridines; Norfloxacin; Ofloxacin; Oxazines; Oxolinic Acid; Pipemidic Acid; Quinolines; Quinolizines; Quinolones | 1986 |
In vitro antibacterial activity of E-3604, a new 6-fluoroquinolone, on clinical isolates.
Topics: Anti-Bacterial Agents; Bacteria; Bacterial Infections; Fluoroquinolones; Humans; Hydrogen-Ion Concentration; Microbial Sensitivity Tests; Norfloxacin; Quinolines; Quinolones | 1987 |
The in-vitro activity of EN 272, a quinolone-7-carboxylic acid, in comparison with other quinolones.
Topics: Anti-Bacterial Agents; Bacteria; Enoxacin; Humans; Microbial Sensitivity Tests; Nalidixic Acid; Naphthyridines; Norfloxacin; Ofloxacin; Oxazines; Quinolines; Quinolones; Structure-Activity Relationship; Urinary Tract Infections | 1985 |
Distribution of quinoline carboxylic acid derivatives in the dog prostate.
Topics: 4-Quinolones; Administration, Oral; Animals; Anti-Infective Agents; Dogs; Drug Evaluation, Preclinical; Infusions, Parenteral; Male; Nalidixic Acid; Norfloxacin; Prostate; Prostatitis; Quinolines; Quinolones; Time Factors; Tissue Distribution; Urinary Tract Infections | 1983 |
[Comparative in vitro effect of 7 quinolones on Ureaplasma urealyticum].
Topics: 4-Quinolones; Anti-Bacterial Agents; Fluoroquinolones; Nalidixic Acid; Norfloxacin; Oxolinic Acid; Pefloxacin; Pipemidic Acid; Quinolines; Quinolizines; Quinolones; Ureaplasma | 1983 |
The activity of ciprofloxacin and other 4-quinolones against Chlamydia trachomatis and Mycoplasmas in vitro.
Topics: 4-Quinolones; Anti-Bacterial Agents; Chlamydia trachomatis; Ciprofloxacin; Dose-Response Relationship, Drug; Humans; Microbial Sensitivity Tests; Mycoplasma; Nalidixic Acid; Norfloxacin; Oxolinic Acid; Oxytetracycline; Quinolines; Quinolones; Ureaplasma | 1984 |
In vitro activities of the spectinomycin analog U-63366 and four quinolone derivatives against Neisseria gonorrhoeae.
Topics: 4-Quinolones; Anti-Bacterial Agents; Ciprofloxacin; Microbial Sensitivity Tests; Nalidixic Acid; Neisseria gonorrhoeae; Norfloxacin; Quinolines; Quinolones; Spectinomycin | 1984 |
Distribution of ciprofloxacin in the dog prostate and various tissues.
Topics: 4-Quinolones; Animals; Anti-Infective Agents; Body Fluids; Ciprofloxacin; Dogs; Hydrogen-Ion Concentration; Infusions, Parenteral; Male; Nalidixic Acid; Norfloxacin; Prostate; Quinolines; Quinolones; Tissue Distribution | 1984 |
In vitro antibacterial activity of three new quinolone derivatives: rosoxacin, norfloxacin, pefloxacin.
Topics: 4-Quinolones; Anti-Infective Agents; Drug Resistance, Microbial; Enterobacteriaceae; Gram-Negative Bacteria; Gram-Positive Bacteria; Nalidixic Acid; Norfloxacin; Pefloxacin; Quinolines; Quinolones; Species Specificity | 1984 |
Comparative in vitro activity of Mk-0366 and other selected oral antimicrobial agents against Neisseria gonorrhoeae.
Topics: 4-Quinolones; Anti-Bacterial Agents; beta-Lactamases; Microbial Sensitivity Tests; Nalidixic Acid; Neisseria gonorrhoeae; Norfloxacin; Quinolines; Quinolones | 1981 |
Reevaluations of disk diffusion susceptibility testing interpretive criteria for lomefloxacin and norfloxacin using fluoroquinolone-resistant isolates.
Topics: Anti-Infective Agents; Drug Resistance, Microbial; Fluoroquinolones; Microbial Sensitivity Tests; Norfloxacin; Quinolones; Sensitivity and Specificity | 1995 |
[In vitro antibacterial activity of balofloxacin (BLFX) against isolates from patients with bacterial enteritis].
Topics: Anti-Infective Agents; Drug Resistance, Microbial; Enteritis; Enterobacteriaceae Infections; Escherichia coli; Fluoroquinolones; Humans; Norfloxacin; Ofloxacin; Quinolones; Salmonella; Shigella | 1995 |
In-vitro activity of new sulphanilil fluoroquinolones against Staphylococcus aureus.
Topics: Anti-Infective Agents; Ciprofloxacin; Fluoroquinolones; Humans; Hydrogen-Ion Concentration; Methicillin Resistance; Microbial Sensitivity Tests; Norfloxacin; Quinolones; Staphylococcal Infections; Staphylococcus aureus; Time Factors | 1994 |
The accumulation of fluoroquinolones in Staphylococcus aureus during the postantibiotic effect.
Topics: Anti-Infective Agents; Biotransformation; Fluoroquinolones; Microbial Sensitivity Tests; Norfloxacin; Pefloxacin; Quinolones; Staphylococcus aureus | 1994 |
In vitro activity of subinhibitory concentrations of quinolones on urea-splitting bacteria: effect on urease activity and on cell surface hydrophobicity.
Topics: Anti-Infective Agents; Ciprofloxacin; Dose-Response Relationship, Drug; Enterobacteriaceae; Fluoroquinolones; Norfloxacin; Ofloxacin; Proteus; Providencia; Quinolones; Surface Properties; Urea; Urease | 1995 |
In vitro phototoxic activities of new quinolone antibacterial agents: lipid peroxidative potentials.
Topics: Absorption; Anti-Infective Agents; Azides; Ciprofloxacin; Dermatitis, Phototoxic; Enoxacin; Fluoroquinolones; Humans; In Vitro Techniques; Lipid Peroxidation; Norfloxacin; Ofloxacin; Oxygen; Photochemistry; Photosensitivity Disorders; Quinolones; Sodium Azide; Squalene; Ultraviolet Rays | 1994 |
Comparative in-vitro activity of rufloxacin with five other antimicrobial agents against bacterial enteric pathogens.
Topics: Ampicillin; Anti-Infective Agents; Campylobacter jejuni; Colistin; Digestive System; Doxycycline; Enterobacteriaceae; Escherichia coli; Fluoroquinolones; Humans; Microbial Sensitivity Tests; Norfloxacin; Quinolones; Trimethoprim, Sulfamethoxazole Drug Combination; Vibrionaceae | 1994 |
The effect of temperature and pH on the solubility of quinolone compounds: estimation of heat of fusion.
Topics: Calorimetry, Differential Scanning; Chromatography, High Pressure Liquid; Ciprofloxacin; Hot Temperature; Hydrogen-Ion Concentration; Norfloxacin; Quinolones; Solubility; Temperature; Thermodynamics | 1994 |
Rapid emergence of quinolone resistance in cirrhotic patients treated with norfloxacin to prevent spontaneous bacterial peritonitis.
Topics: Ascites; Drug Resistance, Microbial; Enterobacteriaceae; Enterobacteriaceae Infections; Feces; Humans; Liver Cirrhosis, Alcoholic; Microbial Sensitivity Tests; Norfloxacin; Peritonitis; Premedication; Quinolones | 1994 |
Correlation between umuC induction and Salmonella mutagenicity assay for quinolone antimicrobial agents.
Topics: Anti-Infective Agents; Bacterial Proteins; Ciprofloxacin; DNA-Directed DNA Polymerase; Enoxacin; Escherichia coli; Escherichia coli Proteins; Fluoroquinolones; Gene Expression Regulation, Bacterial; Mutagenicity Tests; Nalidixic Acid; Naphthyridines; Norfloxacin; Quinolones; Salmonella typhimurium; SOS Response, Genetics; Species Specificity | 1993 |
Induction of resistance of Streptococcus pneumoniae to quinolones in vitro.
Topics: Anti-Infective Agents; Ciprofloxacin; Drug Resistance, Microbial; Fluoroquinolones; Levofloxacin; Microbial Sensitivity Tests; Norfloxacin; Ofloxacin; Quinolones; Streptococcus pneumoniae | 1993 |
Characterization of the complexation of fluoroquinolone antimicrobials with metal ions by nuclear magnetic resonance spectroscopy.
Topics: Anti-Infective Agents; Cations, Divalent; Fluoroquinolones; Magnetic Resonance Spectroscopy; Metals; Molecular Structure; Norfloxacin; Quinolones; X-Ray Diffraction | 1993 |
The in-vitro activity of OPC-17116, a new 5-methyl substituted quinolone.
Topics: Amoxicillin; Anti-Infective Agents; Bacteroides fragilis; Cefaclor; Chlamydia trachomatis; Chlamydophila pneumoniae; Ciprofloxacin; Fluoroquinolones; Haemophilus influenzae; Humans; Microbial Sensitivity Tests; Norfloxacin; Piperazines; Protein Binding; Quinolones; Staphylococcus | 1993 |
Developmental toxicity of fleroxacin and comparative pharmacokinetics of four fluoroquinolones in the cynomolgus macaque (Macaca fascicularis).
Topics: Administration, Oral; Animals; Anti-Infective Agents; Ciprofloxacin; Embryo, Mammalian; Female; Fleroxacin; Fluoroquinolones; Macaca fascicularis; Norfloxacin; Pregnancy; Pregnancy, Animal; Quinolones | 1993 |
Topoisomerase IV is a target of quinolones in Escherichia coli.
Topics: Anti-Bacterial Agents; Ciprofloxacin; DNA Gyrase; DNA Replication; DNA Topoisomerase IV; DNA Topoisomerases, Type II; DNA, Bacterial; Dose-Response Relationship, Drug; Drug Resistance, Microbial; Escherichia coli; Mutation; Norfloxacin; Nucleic Acid Conformation; Quinolones | 1995 |
Proposed criteria for interpretation of susceptibilities of strains of Neisseria gonorrhoeae to ciprofloxacin, ofloxacin, enoxacin, lomefloxacin, and norfloxacin.
Topics: Anti-Infective Agents; Ciprofloxacin; Diffusion; Drug Resistance, Microbial; Enoxacin; Fluoroquinolones; Microbial Sensitivity Tests; Neisseria gonorrhoeae; Norfloxacin; Ofloxacin; Quinolones | 1995 |
In vitro antibacterial activity of FA103, a new quinolone derivative of C-7 position with 7-perhydrodiazepinone.
Topics: Anti-Infective Agents; Azepines; Bacteria; Ciprofloxacin; Drug Resistance, Microbial; Fluoroquinolones; Humans; Norfloxacin; Ofloxacin; Quinolones | 1995 |
[Pharmacokinetics of norfloxacin and lomefloxacin in aqueous humour analysed by microdialysis].
Topics: Animals; Anti-Infective Agents; Aqueous Humor; Fluoroquinolones; Microdialysis; Norfloxacin; Quinolones; Rabbits | 1996 |
Comparative distribution of quinolone antibiotics in cerebrospinal fluid and brain in rats and dogs.
Topics: Animals; Brain; Dogs; Dose-Response Relationship, Drug; Female; Male; Norfloxacin; Quinolones; Rats; Rats, Wistar; Tissue Distribution | 1996 |
DNA strand cleavage is required for replication fork arrest by a frozen topoisomerase-quinolone-DNA ternary complex.
Topics: Deoxyribonucleases, Type II Site-Specific; DNA; DNA Replication; DNA Topoisomerase IV; DNA Topoisomerases, Type II; Electrophoresis, Polyacrylamide Gel; Escherichia coli; Mutagenesis, Site-Directed; Norfloxacin; Nucleic Acid Conformation; Quinolones | 1996 |
[Determination of antimycobacterial activities of fluoroquinolones against clinical isolates of Mycobacterium tuberculosis: comparative determination with egg-based Ogawa and agar-based Middlebrook 7H10 media].
Topics: Anti-Infective Agents; Antitubercular Agents; Ciprofloxacin; Culture Media; Fluoroquinolones; Mycobacterium tuberculosis; Norfloxacin; Ofloxacin; Quinolones | 1996 |
Gyrase mutations in laboratory-selected, fluoroquinolone-resistant mutants of Mycobacterium tuberculosis H37Ra.
Topics: Anti-Infective Agents; Antitubercular Agents; Base Sequence; Cell Wall; Cephaloridine; Ciprofloxacin; DNA Gyrase; DNA Topoisomerases, Type II; Drug Resistance, Microbial; Fluoroquinolones; Genes, Bacterial; Microbial Sensitivity Tests; Mutation; Mycobacterium tuberculosis; Norfloxacin; Ofloxacin; Permeability; Quinolones | 1996 |
Hydrophilicity of quinolones is not an exclusive factor for decreased activity in efflux-mediated resistant mutants of Staphylococcus aureus.
Topics: Anti-Infective Agents; Bacterial Proteins; Carbonyl Cyanide m-Chlorophenyl Hydrazone; DNA Gyrase; DNA Topoisomerase IV; DNA Topoisomerases, Type II; Drug Resistance, Microbial; Escherichia coli; Fluoroquinolones; Microbial Sensitivity Tests; Multidrug Resistance-Associated Proteins; Norfloxacin; Piperazines; Point Mutation; Quinolones; Staphylococcus aureus; Structure-Activity Relationship | 1996 |
[Uptake of 5 fluoroquinolones into human polymorphonuclear cells].
Topics: Anti-Infective Agents; Biological Transport; Fleroxacin; Fluorometry; Fluoroquinolones; Humans; Hydrogen-Ion Concentration; Levofloxacin; Neutrophils; Norfloxacin; Ofloxacin; Quinolones; Temperature | 1996 |
Inhibition of GABAA receptor chloride channel by quinolones and norfloxacin-biphenylacetic acid hybrid compounds.
Topics: Animals; Anti-Infective Agents; Chloride Channels; Chlorine; Enoxacin; GABA Agonists; GABA Antagonists; GABA-A Receptor Antagonists; Male; Muscimol; Norfloxacin; Phenylacetates; Pyridazines; Quinolones; Rats; Rats, Wistar; Synaptosomes | 1996 |
Pharmacokinetic-pharmacodynamic contributions to the convulsant activity of pefloxacin and norfloxacin in rats.
Topics: 4-Quinolones; Animals; Anti-Infective Agents; Brain; Convulsants; Fluoroquinolones; Infusions, Intravenous; Male; Norfloxacin; Pefloxacin; Quinolones; Rats; Rats, Sprague-Dawley; Seizures; Time Factors; Tissue Distribution | 1997 |
Enhanced hematopoiesis in sublethally irradiated mice treated with various quinolones.
Topics: Animals; Anti-Infective Agents; Bone Marrow; Cells, Cultured; Ciprofloxacin; Cobalt Radioisotopes; Colony-Forming Units Assay; Culture Media, Conditioned; Fleroxacin; Fluoroquinolones; Granulocyte-Macrophage Colony-Stimulating Factor; Hematopoiesis; Hematopoietic Stem Cells; Hemoglobins; Interleukin-3; Leukocyte Count; Lymphocytes; Male; Mice; Mice, Inbred BALB C; Norfloxacin; Ofloxacin; Quinolones; Whole-Body Irradiation | 1997 |
In-vitro activity of trovafloxacin against clinical bacterial isolates from patients with cancer.
Topics: Anti-Infective Agents; Ciprofloxacin; Fluoroquinolones; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Levofloxacin; Microbial Sensitivity Tests; Naphthyridines; Neoplasms; Norfloxacin; Ofloxacin; Quinolones | 1997 |
Retention behaviour of quinolone derivatives in high-performance liquid chromatography. Effect of pH and evaluation of ionization constants.
Topics: Acetonitriles; Anti-Infective Agents; Chromatography, High Pressure Liquid; Enoxacin; Fleroxacin; Fluoroquinolones; Hydrogen-Ion Concentration; Norfloxacin; Ofloxacin; Osmolar Concentration; Potentiometry; Quinolizines; Quinolones; Thermodynamics; Water | 1998 |
Photocleavage of DNA by the fluoroquinolone antibacterials.
Topics: Anti-Infective Agents; DNA Damage; Enoxacin; Fleroxacin; Fluoroquinolones; Nalidixic Acid; Norfloxacin; Photolysis; Plasmids; Quinolones; Structure-Activity Relationship; Ultraviolet Rays | 1998 |
Structure and medium-dependent photodecomposition of fluoroquinolone antibiotics.
Topics: Anti-Infective Agents; Enoxacin; Fluoroquinolones; Norfloxacin; Ofloxacin; Photolysis; Photosensitizing Agents; Quantum Theory; Quinolones; Structure-Activity Relationship | 1998 |
The inhibitory effects of the fluoroquinolone antimicrobials norfloxacin and enrofloxacin on hepatic microsomal cytochrome P-450 monooxygenases in broiler chickens.
Topics: Aminopyrine N-Demethylase; Aniline Hydroxylase; Animals; Anti-Infective Agents; Chickens; Cytochrome P-450 Enzyme Inhibitors; Enrofloxacin; Fluoroquinolones; Liver; Male; Microsomes, Liver; Norfloxacin; Organ Size; Quinolones | 1997 |
Synthesis and methemoglobin toxicity of the amides of 6/7 mono or disubstituted quinolone.
Topics: Amides; Animals; Anti-Infective Agents; Ciprofloxacin; Cytochrome-B(5) Reductase; Dogs; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Methemoglobin; Methemoglobinemia; Norfloxacin; Ofloxacin; Quinolones; Structure-Activity Relationship | 1999 |
Electrophoretic behaviour of quinolones in capillary electrophoresis. Effect of pH and evaluation of ionization constants.
Topics: Anti-Infective Agents; Chemical Phenomena; Chemistry, Physical; Ciprofloxacin; Electrophoresis, Capillary; Fluoroquinolones; Hydrogen-Ion Concentration; Ions; Mathematics; Models, Chemical; Molecular Structure; Norfloxacin; Quinolones; Solutions; Water | 1999 |
Structural insight into a quinolone-topoisomerase II-DNA complex. Further evidence for a 2:2 quinobenzoxazine-mg2+ self-assembly model formed in the presence of topoisomerase ii.
Topics: Antineoplastic Agents; Base Pair Mismatch; Base Sequence; Binding Sites; Binding, Competitive; DNA; DNA Topoisomerases, Type II; Hydrogen-Ion Concentration; Intercalating Agents; Models, Chemical; Molecular Sequence Data; Norfloxacin; Oxazines; Quinolones; Topoisomerase II Inhibitors; Ultraviolet Rays; Xanthenes; Xanthones | 1999 |
[The uptake of fluoroquinolone agent drugs by cultured human conjunctival epithelial cells and cultured SIRC rabbit corneal cells].
Topics: Animals; Anti-Infective Agents; Cells, Cultured; Conjunctiva; Cornea; Epithelial Cells; Fluoroquinolones; Humans; Norfloxacin; Ofloxacin; Quinolones; Rabbits | 1999 |
Effect of subinhibitory concentrations of antimicrobial agents (quinolones and macrolide) on the production of verotoxin by enterohemorrhagic Escherichia coli O157:H7.
Topics: Animals; Anti-Infective Agents; Azithromycin; Bacterial Toxins; Chlorocebus aethiops; Clarithromycin; Dose-Response Relationship, Drug; Enterotoxins; Erythromycin; Escherichia coli O157; Fluoroquinolones; Humans; Macrolides; Norfloxacin; Piperazines; Quinolones; Shiga Toxin 1; Time Factors; Vero Cells | 1999 |
Mechanisms involved in the development of resistance to fluoroquinolones in Escherichia coli isolates.
Topics: Anti-Infective Agents; Bacterial Outer Membrane Proteins; DNA Topoisomerase IV; DNA Topoisomerases, Type II; Drug Resistance, Microbial; Drug Resistance, Multiple; Escherichia coli; Escherichia coli Infections; Fluoroquinolones; Humans; Lipopolysaccharides; Microbial Sensitivity Tests; Mutation; Norfloxacin; Quinolones | 1999 |
In vitro phototoxicity of new quinolones: production of active oxygen species and photosensitized lipid peroxidation.
Topics: Anti-Infective Agents; Ciprofloxacin; Dermatitis, Phototoxic; DNA Damage; Fleroxacin; Fluoroquinolones; Humans; Lipid Peroxidation; Norfloxacin; Ofloxacin; Quinolones; Reactive Oxygen Species; Squalene; Time Factors; Ultraviolet Rays | 1999 |
Novel action of quinolones on osteoclast-like cells.
Topics: Animals; Cells, Cultured; Dinoprostone; Histocytochemistry; Male; Mice; Nalidixic Acid; Norfloxacin; Ofloxacin; Osteoclasts; Quinolones; Spleen; Tumor Necrosis Factor-alpha | 1999 |
Synthesis, antibacterial, and cytotoxic evaluation of certain 7-substituted norfloxacin derivatives.
Topics: Anti-Infective Agents; Antineoplastic Agents; Bacteria; Drug Resistance, Microbial; Drug Screening Assays, Antitumor; Humans; Microbial Sensitivity Tests; Norfloxacin; Piperazines; Quinolones; Structure-Activity Relationship; Tumor Cells, Cultured | 2000 |
Damage to mitochondria of cultured human skin fibroblasts photosensitized by fluoroquinolones.
Topics: Anti-Infective Agents; Cells, Cultured; Ciprofloxacin; Cytoplasm; Fibroblasts; Fluoroquinolones; Humans; Mitochondria; Norfloxacin; Ofloxacin; Photosensitizing Agents; Quinolones; Skin | 2000 |
Nonenteric Escherichia coli isolates from dogs: 674 cases (1990-1998).
Topics: Amikacin; Animals; Anti-Bacterial Agents; Anti-Infective Agents; Dog Diseases; Dogs; Drug Resistance, Microbial; Enrofloxacin; Escherichia coli; Escherichia coli Infections; Female; Fluoroquinolones; Gentamicins; Infections; Male; Microbial Sensitivity Tests; Norfloxacin; Quinolones; Respiratory System; Retrospective Studies; Skin; Urine | 2001 |
Comparison of the in vitro activities of BMS-284756 and four fluoroquinolones against Streptococcus pneumoniae.
Topics: Anti-Infective Agents; Aza Compounds; Ciprofloxacin; Fluoroquinolones; Humans; Indoles; Microbial Sensitivity Tests; Moxifloxacin; Norfloxacin; Quinolines; Quinolones; Streptococcus pneumoniae | 2001 |
[Degradation of liquid preparations of four fluoroquinolones by factorial experiment. ].
Topics: Anti-Infective Agents; Ciprofloxacin; Fluoroquinolones; Hydrogen-Ion Concentration; Light; Norfloxacin; Ofloxacin; Quinolones | 1997 |
[Studies on pyridonecarboxylic acids as antibacterial agents. XII. Synthesis and antibacterial activity of 6-chloro-1-cyclopropyl-7-(1-piperazinyl)-1, 4-dihydro-4-oxo-quinoline-3-carboxylic acid and analogues].
Topics: Animals; Anti-Infective Agents; Carboxylic Acids; Ciprofloxacin; Escherichia coli; Mice; Norfloxacin; Pseudomonas aeruginosa; Pyridones; Quinolones; Staphylococcal Infections; Staphylococcus aureus | 1997 |
Studies on the uptake and release of fluoroquinolones by disposable contact lenses.
Topics: Anti-Infective Agents; Chromatography, High Pressure Liquid; Contact Lenses, Hydrophilic; Disposable Equipment; Drug Delivery Systems; Fluoroquinolones; Norfloxacin; Ofloxacin; Quinolones | 2001 |
Interaction of fluoroquinolones and certain ionophores in broilers: effect on blood levels and hepatic cytochrome p450 monooxygenase activity.
Topics: Aminopyrine N-Demethylase; Aniline Hydroxylase; Animals; Anti-Infective Agents; Chickens; Coccidiostats; Cytochrome P-450 Enzyme System; Drug Interactions; Enrofloxacin; Fluoroquinolones; Lasalocid; Male; Microsomes, Liver; Monensin; Norfloxacin; Quinolones | 2001 |
Osteoadsorptive bisphosphonate derivatives of fluoroquinolone antibacterials.
Topics: Animals; Anti-Infective Agents; Bone and Bones; Ciprofloxacin; Diphosphonates; Enoxacin; Gram-Negative Bacteria; Gram-Positive Bacteria; Hydrogen-Ion Concentration; In Vitro Techniques; Microbial Sensitivity Tests; Norfloxacin; Piperazines; Quinolones; Rats; Spectrometry, Fluorescence; Structure-Activity Relationship; Swine | 2002 |
[Drug interactions between nonsteroidal anti-inflammatory drug and pazufloxacin mesilate, a new quinolone antibacterial agent for intravenous use: convulsions in mice after intravenous or intracerebroventricular administration].
Topics: Administration, Oral; Animals; Anti-Bacterial Agents; Anti-Infective Agents; Anti-Inflammatory Agents, Non-Steroidal; beta-Alanine; Biphenyl Compounds; Cefazolin; Cilastatin; Cilastatin, Imipenem Drug Combination; Ciprofloxacin; Convulsants; Drug Combinations; Drug Interactions; Enoxacin; Fleroxacin; Fluoroquinolones; Imipenem; Injections, Intravenous; Injections, Intraventricular; Male; Mice; Mice, Inbred ICR; Norfloxacin; Oxazines; Penicillin G; Quinolones; Seizures; Thienamycins | 2002 |
Comparative articular toxicity of garenoxacin, a novel quinolone antimicrobial agent, in juvenile beagle dogs.
Topics: Administration, Oral; Animals; Anti-Infective Agents; Cartilage, Articular; Ciprofloxacin; Dogs; Dose-Response Relationship, Drug; Female; Fluoroquinolones; Indoles; Injections, Intravenous; Joint Diseases; Male; Norfloxacin; Quinolones; Toxicity Tests | 2002 |
Laser flash photolysis study of photoionization in fluoroquinolones.
Topics: Anti-Infective Agents; Electron Transport; Enoxacin; Fluoroquinolones; Lasers; Norfloxacin; Photochemistry; Photolysis; Photons; Quantum Theory; Quinolones; Solutions; Time Factors; Water | 2002 |
Reliability of phototoxic tests of fluoroquinolones in vitro.
Topics: 3T3 Cells; Animals; Anti-Infective Agents; Ciprofloxacin; Cricetinae; Cricetulus; Dermatitis, Phototoxic; Female; Fluoroquinolones; Mice; Mice, Inbred BALB C; Micronucleus Tests; Norfloxacin; Quinolones; Rats; Rats, Wistar; Ultraviolet Rays | 2003 |
Effects of lomefloxacin and norfloxacin on pancreatic beta-cell ATP-sensitive K(+) channels.
Topics: Animals; Anti-Infective Agents; Cell Line; Dose-Response Relationship, Drug; Electrophysiology; Fluoroquinolones; Islets of Langerhans; Models, Chemical; Norfloxacin; Potassium Channels; Quinolinic Acid; Quinolones; Rats | 2003 |
Simultaneous measurement of fluoroquinolones in eggs by a combination of supercritical fluid extraction and high pressure liquid chromatography.
Topics: Anti-Bacterial Agents; Calibration; Chromatography, High Pressure Liquid; Chromatography, Supercritical Fluid; Ciprofloxacin; Eggs; Enrofloxacin; Fluoroquinolones; Food Contamination; Norfloxacin; Ofloxacin; Quinolones; Solvents | 2003 |
[Studies on correlation between protonation and tautomerism and luminescence characteristics of quinolone].
Topics: Anti-Infective Agents; Chemical Phenomena; Chemistry, Physical; Ciprofloxacin; Energy Transfer; Fluoroquinolones; Hydrogen-Ion Concentration; Luminescence; Molecular Structure; Norfloxacin; Piperazines; Protons; Quinolones; Spectrometry, Fluorescence; Stereoisomerism; Structure-Activity Relationship | 2001 |
Binding characteristics of fluoroquinolones to synthetic levodopa melanin.
Topics: Binding Sites; Chloroquine; Ciprofloxacin; Drug Interactions; Enoxacin; Fluoroquinolones; Levodopa; Levofloxacin; Melanins; Monophenol Monooxygenase; Norfloxacin; Ofloxacin; Quinolones; Timolol | 2003 |
[Study of filter-paper-substrate delay fluorescence of three quinolones].
Topics: Anti-Infective Agents; Filtration; Hydrogen-Ion Concentration; Norfloxacin; Pefloxacin; Pipemidic Acid; Quinolones; Spectrometry, Fluorescence | 2003 |
The RuvAB branch migration complex can displace topoisomerase IV.quinolone.DNA ternary complexes.
Topics: Bacterial Proteins; Catalysis; DNA; DNA Helicases; DNA Topoisomerase IV; DNA-Binding Proteins; Dose-Response Relationship, Drug; Enzyme Inhibitors; Escherichia coli; Escherichia coli Proteins; Models, Genetic; Norfloxacin; Protein Binding; Protein Transport; Quinolones; Recombination, Genetic; Time Factors | 2003 |
Aqueous humor levels of topically applied levofloxacin, norfloxacin, and lomefloxacin in the same human eyes.
Topics: Aged; Aged, 80 and over; Anti-Infective Agents; Anti-Infective Agents, Urinary; Aqueous Humor; Chromatography, High Pressure Liquid; Female; Fluoroquinolones; Humans; Levofloxacin; Male; Norfloxacin; Ofloxacin; Quinolones | 2003 |
Synthesis and in vitro antibacterial evaluation of N-[5-(5-nitro-2-thienyl)-1,3,4-thiadiazole-2-yl] piperazinyl quinolones.
Topics: Anti-Bacterial Agents; Bacteria; Ciprofloxacin; Enoxacin; Microbial Sensitivity Tests; Norfloxacin; Piperazine; Piperazines; Quinolones | 2003 |
Corneal and scleral permeability of quinolones--a pharmacokinetics study.
Topics: Administration, Topical; Animals; Aqueous Humor; Cell Membrane Permeability; Cinoxacin; Ciprofloxacin; Conjunctiva; Cornea; Enoxacin; Nalidixic Acid; Norfloxacin; Ofloxacin; Quinolones; Rabbits; Sclera; Time Factors; Water | 2003 |
Replacement of ParC alpha4 helix with that of GyrA increases the stability and cytotoxicity of topoisomerase IV-quinolone-DNA ternary complexes.
Topics: Anti-Infective Agents; Cloning, Molecular; DNA Gyrase; DNA Topoisomerase IV; DNA, Bacterial; Drug Resistance, Bacterial; Escherichia coli; Mutation; Norfloxacin; Quinolones | 2004 |
Atomic absorption spectroscopic, conductometric and colorimetric methods for determination of fluoroquinolone antibiotics using ammonium reineckate ion-pair complex formation.
Topics: Absorption; Acetone; Anti-Bacterial Agents; Ciprofloxacin; Colorimetry; Dose-Response Relationship, Drug; Electric Conductivity; Enrofloxacin; Fluoroquinolones; Hydrogen-Ion Concentration; Ions; Linear Models; Norfloxacin; Ofloxacin; Quaternary Ammonium Compounds; Quinolones; Salts; Solvents; Spectrophotometry, Atomic; Thiocyanates | 2004 |
[Study on the molecular mechanism of quinolone resistance in Shigellae spp].
Topics: Anti-Infective Agents; Ciprofloxacin; DNA Gyrase; DNA Topoisomerase IV; Drug Resistance, Bacterial; Humans; Microbial Sensitivity Tests; Norfloxacin; Ofloxacin; Pipemidic Acid; Polymerase Chain Reaction; Polymorphism, Single-Stranded Conformational; Quinolones; Shigella | 2004 |
Reduction of the fitness burden of quinolone resistance in Pseudomonas aeruginosa.
Topics: Anti-Infective Agents; Bacterial Proteins; Culture Media; DNA Gyrase; DNA Topoisomerase IV; DNA-Binding Proteins; Drug Resistance, Bacterial; Evolution, Molecular; Humans; Microbial Sensitivity Tests; Mutation; Norfloxacin; Pseudomonas aeruginosa; Quinolones; Transcription Factors | 2005 |
Antibiotic sensitivity patterns among Indian strains of avian Pasteurella multocida.
Topics: Animals; Anti-Bacterial Agents; Chloramphenicol; Doxycycline; Enrofloxacin; Fluoroquinolones; India; Lincomycin; Microbial Sensitivity Tests; Norfloxacin; Pasteurella Infections; Pasteurella multocida; Poultry; Poultry Diseases; Quinolones; Species Specificity; Sulfadiazine | 2004 |
Norfloxacin decreases bacterial adherence of quinolone-resistant strains of Escherichia coli isolated from patients with cirrhosis.
Topics: Anti-Infective Agents; Bacterial Adhesion; Drug Resistance, Bacterial; Escherichia coli; Humans; Inhibitory Concentration 50; Liver Cirrhosis; Mouth Mucosa; Norfloxacin; Quinolones | 2005 |
Vibrational spectroscopic characterization of fluoroquinolones.
Topics: Aza Compounds; Cinoxacin; Ciprofloxacin; DNA Gyrase; DNA, Bacterial; Enoxacin; Enzyme Inhibitors; Fluoroquinolones; Hydrogen Bonding; Hydrogen-Ion Concentration; Models, Chemical; Models, Molecular; Models, Theoretical; Moxifloxacin; Nalidixic Acid; Norfloxacin; Ofloxacin; Oxolinic Acid; Quinolines; Quinolones; Spectrophotometry, Infrared; Spectrum Analysis, Raman; Temperature; Ultraviolet Rays; Vibration; Water | 2005 |
The simultaneous separation and determination of five quinolone antibiotics using isocratic reversed-phase HPLC: application to stability studies on an ofloxacin tablet formulation.
Topics: Anti-Bacterial Agents; Calibration; Chemistry, Pharmaceutical; Chromatography; Chromatography, High Pressure Liquid; Ciprofloxacin; Dose-Response Relationship, Drug; Drug Industry; Drug Stability; Fluoroquinolones; Hydrogen-Ion Concentration; Models, Chemical; Nalidixic Acid; Norfloxacin; Ofloxacin; Quinolones; Reproducibility of Results; Tablets; Time Factors | 2005 |
Inhibition of cell differentiation by quinolones in micromass cultures of rat embryonic limb bud and midbrain cells.
Topics: Animals; Anti-Infective Agents; Cell Differentiation; Cell Proliferation; Cell Survival; Ciprofloxacin; Dose-Response Relationship, Drug; Embryo Culture Techniques; Enrofloxacin; Fluoroquinolones; Inhibitory Concentration 50; Limb Buds; Mesencephalon; Norfloxacin; Quinolones; Rats; Rats, Wistar | 2005 |
Interactions between 4-quinolone antibacterials and multivalent metal ions.
Topics: Anti-Bacterial Agents; Ciprofloxacin; Gram-Negative Bacteria; Metals; Microbial Sensitivity Tests; Norfloxacin; Ofloxacin; Quinolones | 1989 |
The use of quinolones in the treatment of acute bacterial diarrhea: a comparative therapeutic trial.
Topics: Acute Disease; Adolescent; Anti-Infective Agents; Bacteria; Bacterial Infections; Chloramphenicol; Diarrhea; Feces; Female; Humans; Male; Norfloxacin; Quinolones; Randomized Controlled Trials as Topic; Tetracycline; Trimethoprim, Sulfamethoxazole Drug Combination | 1989 |
T cell-mediated hypersensitivity to quinolones: mechanisms and cross-reactivity.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Antigen-Presenting Cells; Aza Compounds; Cell Proliferation; Cells, Cultured; Ciprofloxacin; Clone Cells; Cross Reactions; Drug Hypersensitivity; Enoxacin; Female; Fluoroquinolones; Humans; Hypersensitivity, Delayed; Middle Aged; Moxifloxacin; Nalidixic Acid; Norfloxacin; Ofloxacin; Patch Tests; Pipemidic Acid; Quinolines; Quinolones; T-Lymphocytes | 2006 |
Selective action of fluoroquinolones against intracellular amastigotes of Leishmania (Viannia) panamensis in vitro.
Topics: Animals; Cell Line; Cinoxacin; Ciprofloxacin; Enoxacin; Fluoroquinolones; Humans; Leishmania guyanensis; Macrophages; Nalidixic Acid; Norfloxacin; Ofloxacin; Quinolones | 2005 |
Transfection of drug-specific T-cell receptors into hybridoma cells: tools to monitor drug interaction with T-cell receptors and evaluate cross-reactivity to related compounds.
Topics: Animals; B-Lymphocytes; CD3 Complex; CD4 Antigens; Cell Line, Transformed; Cells, Cultured; Ciprofloxacin; Cross Reactions; Drug Interactions; Flow Cytometry; Humans; Hybridomas; Interleukin-2; Mice; Norfloxacin; Quinolones; Receptors, Antigen, T-Cell; Sulfamethizole; Sulfamethoxazole; Sulfanilamides; T-Lymphocytes; Time Factors; Transfection | 2006 |
Corneal penetration of simultaneously applied topical levofloxacin, norfloxacin and lomefloxacin in human eyes.
Topics: Administration, Topical; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Chromatography, High Pressure Liquid; Cornea; Female; Fluoroquinolones; Humans; Keratoplasty, Penetrating; Levofloxacin; Male; Middle Aged; Norfloxacin; Ofloxacin; Quinolones; Tissue Distribution | 2006 |
[Synchronous fluorimetric determination of the residues of three quinolones in Eel by partial least squares].
Topics: Animals; Anti-Bacterial Agents; Drug Residues; Eels; Fluorometry; Fluoroquinolones; Least-Squares Analysis; Levofloxacin; Norfloxacin; Ofloxacin; Quinolones; Seafood | 2006 |
Determination of selected antibiotics in the Victoria Harbour and the Pearl River, South China using high-performance liquid chromatography-electrospray ionization tandem mass spectrometry.
Topics: Amoxicillin; Anti-Bacterial Agents; China; Chloramphenicol; Chromatography, High Pressure Liquid; Climate; Erythromycin; Hong Kong; Macrolides; Norfloxacin; Ofloxacin; Quinolones; Rivers; Seasons; Seawater; Spectrometry, Mass, Electrospray Ionization; Sulfanilamides; Time Factors; Waste Management; Water Pollutants, Chemical | 2007 |
A kinetic method amenable to automation for ceruloplasmin estimation with inexpensive and stable reagents.
Topics: Adult; Ceruloplasmin; Clinical Chemistry Tests; Dithiothreitol; Female; Ferrozine; Hepatolenticular Degeneration; Humans; Hydrogen-Ion Concentration; Kinetics; Male; Norfloxacin; Pregnancy; Quinolones; Reproducibility of Results | 2007 |
[Determination of 16 quinolone residues in animal tissues using high performance liquid chromatography coupled with electrospray ionization tandem mass spectrometry].
Topics: Animals; Chromatography, High Pressure Liquid; Ciprofloxacin; Enoxacin; Enrofloxacin; Fluoroquinolones; Norfloxacin; Ofloxacin; Pefloxacin; Quinolones; Reproducibility of Results; Spectrometry, Mass, Electrospray Ionization | 2007 |
Determination of ulifloxacin by terbium-sensitized fluorescence with second-order scattering and its applications.
Topics: Anti-Bacterial Agents; Fluoroquinolones; Humans; Indicators and Reagents; Luminescence; Norfloxacin; Ofloxacin; Piperazines; Quinolones; Scattering, Radiation; Spectrometry, Fluorescence; Terbium | 2007 |
Plasmid-mediated QnrS2 determinant from a clinical Aeromonas veronii isolate.
Topics: Aeromonas; Ciprofloxacin; Drug Resistance, Bacterial; Genes, Bacterial; Gram-Negative Bacterial Infections; Humans; Microbial Sensitivity Tests; Nalidixic Acid; Norfloxacin; Plasmids; Quinolones | 2008 |
Study of fluorescence characteristics of the charge-transfer reaction of quinolone agents with bromanil.
Topics: Anti-Bacterial Agents; Benzoquinones; Catalysis; Ciprofloxacin; Electrons; Energy Transfer; Models, Biological; Norfloxacin; Ofloxacin; Osmolar Concentration; Quinolones; Solvents; Spectrometry, Fluorescence; Technology, Pharmaceutical; Temperature; Time Factors | 2009 |
Determination of quinolone antibiotics in urine by capillary electrophoresis with chemiluminescence detection.
Topics: Anti-Infective Agents; Ciprofloxacin; Electrophoresis, Capillary; Humans; Luminescent Measurements; Molecular Structure; Norfloxacin; Ofloxacin; Quinolones; Sensitivity and Specificity; Solvents | 2008 |
[Multi-residue determination of 11 quinolones in chicken muscle by high performance liquid chromatography with fluorescence detection].
Topics: Animals; Chickens; Chromatography, High Pressure Liquid; Ciprofloxacin; Drug Residues; Fluorescence; Norfloxacin; Ofloxacin; Poultry Products; Quinolones | 2009 |
[Preliminary study on occurrence and health risk assessment of quinolone antibiotics in vegetables from Guangzhou, China].
Topics: Anti-Bacterial Agents; China; Chromatography, High Pressure Liquid; Ciprofloxacin; Fluoroquinolones; Food Contamination; Norfloxacin; Quinolones; Risk Assessment; Urban Health; Vegetables | 2010 |
Resistance to topoisomerase cleavage complex induced lethality in Escherichia coli via titration of transcription regulators PurR and FNR.
Topics: DNA Topoisomerases, Type I; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Proteins; Iron-Sulfur Proteins; Norfloxacin; Oxidative Stress; Quinolones; Repressor Proteins; Transcription Factors; Yersinia | 2011 |
Spectroscopic study of degradation products of ciprofloxacin, norfloxacin and lomefloxacin formed in ozonated wastewater.
Topics: Chromatography, High Pressure Liquid; Ciprofloxacin; Fluoroquinolones; Mass Spectrometry; Norfloxacin; Oxidation-Reduction; Ozone; Piperazine; Piperazines; Quinolones; Waste Disposal, Fluid; Wastewater; Water Pollutants, Chemical | 2012 |
Effect of pH on the in vitro susceptibility of planktonic and biofilm-grown Proteus mirabilis to the quinolone antimicrobials.
Topics: Anti-Bacterial Agents; Biofilms; Ciprofloxacin; Hydrogen-Ion Concentration; Microbial Sensitivity Tests; Nalidixic Acid; Norfloxacin; Plankton; Proteus mirabilis; Quinolones | 2013 |
Mannich bases of 7-piperazinylquinolones and kojic acid derivatives: synthesis, in vitro antibacterial activity and in silico study.
Topics: Anti-Bacterial Agents; Mannich Bases; Microbial Sensitivity Tests; Molecular Docking Simulation; Molecular Structure; Norfloxacin; Piperazines; Pyrones; Quinolones | 2013 |
Determination of five quinolone antibiotic residues in foods by micellar electrokinetic capillary chromatography with quantum dot indirect laser-induced fluorescence.
Topics: Animal Feed; Animals; Anti-Bacterial Agents; Cadmium Compounds; Chromatography, Micellar Electrokinetic Capillary; Ciprofloxacin; Enrofloxacin; European Union; Fluorescence; Fluoroquinolones; Hydrogen-Ion Concentration; Japan; Lasers; Limit of Detection; Loxapine; Norfloxacin; Quantum Dots; Quinolones; Spectrometry, Fluorescence; Tellurium | 2014 |
[Simultaneous determination of clopidol, sulfonamide and quinolone residues in chickens by ultra performance liquid chromatography-tandem mass spectrometry].
Topics: Animals; Chickens; Chromatography, High Pressure Liquid; Ciprofloxacin; Clopidol; Drug Residues; Enrofloxacin; Fluoroquinolones; Food Contamination; Hexanes; Meat; Norfloxacin; Ofloxacin; Quinolones; Sulfanilamide; Sulfanilamides; Sulfonamides; Tandem Mass Spectrometry | 2013 |
Analysis of quinolone antibiotics in eggs: preparation and characterization of a raw material for method validation and quality control.
Topics: Anti-Bacterial Agents; Chromatography, Liquid; Ciprofloxacin; Eggs; Enrofloxacin; Fluoroquinolones; Food Contamination; Norfloxacin; Oxolinic Acid; Quality Control; Quinolones; Reproducibility of Results | 2012 |
Responses of plasmid-mediated quinolone resistance genes and bacterial taxa to (fluoro)quinolones-containing manure in arable soil.
Topics: Anti-Bacterial Agents; Ciprofloxacin; Drug Resistance, Bacterial; Enrofloxacin; Fluoroquinolones; Genes, Bacterial; Gram-Negative Bacteria; Manure; Norfloxacin; Plasmids; Quinolones; Selection, Genetic; Soil; Species Specificity; Time Factors | 2015 |
Association of mutation patterns in GyrA and ParC genes with quinolone resistance levels in lactic acid bacteria.
Topics: Amino Acid Sequence; Anti-Bacterial Agents; Ciprofloxacin; Cultured Milk Products; DNA Gyrase; DNA Topoisomerase IV; DNA Topoisomerases, Type II; Drug Resistance, Bacterial; Enterococcus; Lactic Acid; Lactobacillus; Microbial Sensitivity Tests; Mutation; Norfloxacin; Quinolones; Yogurt | 2015 |
[Role of double strand DNA break repair for quinolone sensitivity in Escherichia coli: therapeutic implications].
Topics: Anti-Bacterial Agents; Bacterial Proteins; Ciprofloxacin; DNA Breaks, Double-Stranded; DNA Helicases; DNA Repair; DNA Replication; DNA, Bacterial; Drug Resistance, Multiple, Bacterial; Escherichia coli; Escherichia coli Infections; Escherichia coli Proteins; Exodeoxyribonuclease V; Genes, Bacterial; Humans; Microbial Sensitivity Tests; Molecular Targeted Therapy; Nalidixic Acid; Norfloxacin; Quinolones; Rec A Recombinases; Recombinational DNA Repair; Serine Endopeptidases; SOS Response, Genetics | 2015 |
Design and biological evaluation of novel quinolone-based metronidazole derivatives as potent Cu(2+) mediated DNA-targeting antibacterial agents.
Topics: Animals; Anti-Bacterial Agents; Antifungal Agents; Chemistry Techniques, Synthetic; Ciprofloxacin; Copper; DNA, Bacterial; Drug Evaluation, Preclinical; Fibroblasts; Fluoroquinolones; HEK293 Cells; Humans; Metronidazole; Mice; Microbial Sensitivity Tests; Molecular Targeted Therapy; Norfloxacin; Pseudomonas aeruginosa; Quinolones; Structure-Activity Relationship | 2015 |
[Determination of 25 quinolones in cosmetics by liquid chromatography-tandem mass spectrometry].
Topics: Chromatography, Liquid; Ciprofloxacin; Cosmetics; Drug Residues; Enrofloxacin; Fluoroquinolones; Hexanes; Norfloxacin; Ofloxacin; Quinolones; Spectrometry, Mass, Electrospray Ionization; Tandem Mass Spectrometry | 2015 |
Impact of AAC(6')-Ib-cr in combination with chromosomal-mediated mechanisms on clinical quinolone resistance in Escherichia coli.
Topics: Animals; Anti-Bacterial Agents; Chromosomes, Bacterial; Ciprofloxacin; Disease Models, Animal; Escherichia coli; Escherichia coli Infections; Genes, Bacterial; Male; Mice, Inbred C57BL; Microbial Sensitivity Tests; Microbial Viability; Norfloxacin; Peritonitis; Plasmids; Quinolones; Sepsis; Virulence | 2016 |
Quantitative and automated MALDI-TOF MS-based detection of the plasmid-mediated quinolone resistance determinant AAC(6')-Ib-cr in Enterobacteriaceae.
Topics: Acetylation; Acetyltransferases; Anti-Bacterial Agents; Ciprofloxacin; Drug Resistance, Bacterial; Enterobacteriaceae; Norfloxacin; Plasmids; Quinolones; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization; Time Factors | 2017 |
Highly Water-Stable Dye@Ln-MOFs for Sensitive and Selective Detection toward Antibiotics in Water.
Topics: Anti-Bacterial Agents; Ciprofloxacin; Norfloxacin; Quinolones; Reproducibility of Results; Water; X-Ray Diffraction | 2019 |
Using hapten cross-reactivity to screen heterologous competitive antigens for improving the sensitivity of ELISA.
Topics: Antigens, Heterophile; Cross Reactions; Enzyme-Linked Immunosorbent Assay; Haptens; Molecular Docking Simulation; Norfloxacin; Quinolones; Serum Albumin, Bovine | 2020 |
Development of quinolone resistance and prevalence of different virulence genes among Shigella flexneri and Shigella dysenteriae in environmental water samples.
Topics: Anti-Bacterial Agents; Ciprofloxacin; Drug Resistance, Bacterial; Humans; India; Membrane Transport Proteins; Microbial Sensitivity Tests; Norfloxacin; Ofloxacin; Plasmids; Prevalence; Quinolones; Shigella dysenteriae; Shigella flexneri; Virulence | 2020 |
Multi-phase distribution, spatiotemporal variation and risk assessment of antibiotics in a typical urban-rural watershed.
Topics: Anti-Bacterial Agents; China; Ciprofloxacin; Cities; Environmental Monitoring; Geologic Sediments; Lakes; Norfloxacin; Particulate Matter; Quinolones; Risk Assessment; Rivers; Seasons; Tetracycline; Water Pollutants, Chemical | 2020 |
Basophil activation test in the diagnosis of hypersensitivity reactions to quinolones in a real-life setting.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Basophil Degranulation Test; Ciprofloxacin; Drug Hypersensitivity; Female; Humans; Levofloxacin; Male; Middle Aged; Moxifloxacin; Norfloxacin; Quinolones; Skin Tests; Young Adult | 2021 |
The influence mechanism of the molecular structure on the peak current and peak potential in electrochemical detection of typical quinolone antibiotics.
Topics: Anti-Bacterial Agents; Catalysis; Electrochemical Techniques; Enoxacin; Molecular Structure; Norfloxacin; Ofloxacin; Oxidation-Reduction; Quinolones; Water; Water Pollutants, Chemical | 2021 |
Estimating antibiotics use in major cities in China through wastewater-based epidemiology.
Topics: Anti-Bacterial Agents; China; Cities; Humans; Norfloxacin; Quinolones; Wastewater; Wastewater-Based Epidemiological Monitoring; Water Pollutants, Chemical | 2022 |
Validation of a random
Topics: Anti-Bacterial Agents; Drug Resistance, Bacterial; Escherichia coli; Genomic Library; Norfloxacin; Quinolones; Vibrio parahaemolyticus | 2022 |
Quinolone distribution, trophodynamics, and human exposure risk in a transit-station lake for water diversion in east China.
Topics: China; Environmental Monitoring; Geologic Sediments; Humans; Norfloxacin; Quinolones; Risk Assessment; Water; Water Pollutants, Chemical | 2022 |
Molecular characteristics of fluoroquinolone-resistant Escherichia coli isolated from suckling piglets with colibacillosis.
Topics: Aminoglycosides; Animals; Anti-Bacterial Agents; beta-Lactamases; Ciprofloxacin; DNA Gyrase; Enrofloxacin; Escherichia coli; Escherichia coli Infections; Fluoroquinolones; Norfloxacin; Quinolones; Sulfonamides; Swine | 2022 |
New Efforts toward Aminothiazolylquinolones with Multitargeting Antibacterial Potential.
Topics: Animals; Anti-Bacterial Agents; Bacteria; DNA; Mammals; Microbial Sensitivity Tests; Norfloxacin; Quinolones; Staphylococcus aureus | 2023 |
Benzopyrone-mediated quinolones as potential multitargeting antibacterial agents.
Topics: Anti-Bacterial Agents; Benzopyrans; DNA Gyrase; Humans; Microbial Sensitivity Tests; Norfloxacin; Quinolones | 2023 |